doi: 10.1155/2020/9140907
CJC-1295 with DAC binds GHRH-R on somatotrophs and provides sustained GHRH-axis stimulation across days, but it depends on endogenous ghrelin tone for GHS-R1a input
For MACE-4, the HR was 0.80 (95% CI, 0.571.11) for tirzepatide versus standard therapy, the HR for cardiovascular death 0.90 (95% CI, 0.501.61) and 0.80 (95% CI, 0.511.25) for all-cause death
NICE health technology appraisal would follow regulatory approval before NHS access could be considered
They approach what bariatric surgery produces, which is roughly 25 to 30% weight reduction, and they do so with a weekly subcutaneous injection rather than a surgical procedure
Prescription only if a licensed clinician decides it's appropriate